BRM
XYL icon

Boston Research & Management’s Xylem XYL Stock Holding History

Boston Research & Management’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Sell
56,127
-1,518
-3% -$199K 1.59% 25
2025
Q4 		$7.85M Sell
57,645
-7,029
-11% -$1.01M 1.81% 14
2025
Q3 		$9.54M Sell
64,674
-15
-0% -$2.08K 2.1% 13
2025
Q2 		$8.37M Sell
64,689
-128
-0.2% -$15.5K 2% 13
2025
Q1 		$7.74M Sell
64,817
-345
-0.5% -$42.8K 1.92% 14
2024
Q4 		$7.56M Sell
65,162
-544
-0.8% -$68.8K 1.86% 15
2024
Q3 		$8.87M Buy
65,706
+1,230
+2% +$165K 2.08% 9
2024
Q2 		$8.74M Sell
64,476
-1,166
-2% -$159K 2.21% 9
2024
Q1 		$8.48M Sell
65,642
-50
-0.1% -$6.04K 2.1% 7
2023
Q4 		$7.51M Buy
65,692
+1,572
+2% +$157K 1.99% 10
2023
Q3 		$5.84M Buy
64,120
+620
+1% +$63.9K 1.73% 19
2023
Q2 		$7.15M Buy
63,500
+65
+0.1% +$6.87K 2.02% 12
2023
Q1 		$6.64M Buy
63,435
+360
+0.6% +$37.6K 1.98% 12
2022
Q4 		$6.97M Sell
63,075
-275
-0.4% -$28.8K 2.16% 8
2022
Q3 		$5.53M Buy
63,350
+515
+0.8% +$46.8K 1.89% 14
2022
Q2 		$4.91M Buy
62,835
+1,145
+2% +$94.5K 1.59% 23
2022
Q1 		$5.26M Sell
61,690
-1,207
-2% -$116K 1.53% 23
2021
Q4 		$7.54M Buy
62,897
+255
+0.4% +$31.6K 2.06% 13
2021
Q3 		$7.75M Sell
62,642
-475
-0.8% -$61.1K 2.31% 7
2021
Q2 		$7.57M Sell
63,117
-595
-0.9% -$67.9K 2.3% 8
2021
Q1 		$6.7M Sell
63,712
-990
-2% -$100K 2.16% 10
2020
Q4 		$6.59M Sell
64,702
-655
-1% -$61.6K 2.29% 7
2020
Q3 		$5.5M Sell
65,357
-2,135
-3% -$166K 2.15% 13
2020
Q2 		$4.38M Buy
67,492
+1,487
+2% +$98.1K 1.82% 19
2020
Q1 		$4.3M Sell
66,005
-1,386
-2% -$109K 2.16% 15
2019
Q4 		$5.31M Buy
67,391
+294
+0.4% +$22.9K 1.99% 12
2019
Q3 		$5.34M Buy
67,097
+1,145
+2% +$90K 2.11% 11
2019
Q2 		$5.52M Sell
65,952
-790
-1% -$62.9K 2.23% 8
2019
Q1 		$5.28M Buy
66,742
+710
+1% +$51.8K 2.2% 8
2018
Q4 		$4.41M Buy
66,032
+9,900
+18% +$685K 2.1% 14
2018
Q3 		$4.48M Buy
56,132
+140
+0.3% +$10.5K 2.05% 8
2018
Q2 		$3.77M Buy
55,992
+180
+0.3% +$13.1K 1.86% 18
2018
Q1 		$4.29M Sell
55,812
-2,500
-4% -$185K 2.19% 10
2017
Q4 		$3.98M Sell
58,312
-3,630
-6% -$241K 1.99% 18
2017
Q3 		$3.88M Sell
61,942
-860
-1% -$51.4K 1.98% 15
2017
Q2 		$3.48M Sell
62,802
-180
-0.3% -$9.37K 1.88% 20
2017
Q1 		$3.16M Sell
62,982
-2,750
-4% -$134K 1.72% 27
2016
Q4 		$3.25M Sell
65,732
-2,180
-3% -$111K 1.85% 19
2016
Q3 		$3.56M Sell
67,912
-1,620
-2% -$79.4K 2.06% 9
2016
Q2 		$3.1M Sell
69,532
-1,640
-2% -$71.3K 1.88% 17
2016
Q1 		$2.91M Buy
71,172
+340
+0.5% +$12.5K 1.81% 21
2015
Q4 		$2.58M Buy
70,832
+200
+0.3% +$7.23K 1.61% 23
2015
Q3 		$2.32M Sell
70,632
-960
-1% -$32.3K 1.53% 27
2015
Q2 		$2.65M Sell
71,592
-160
-0.2% -$5.82K 1.68% 25
2015
Q1 		$2.51M Buy
71,752
+2,450
+4% +$86.4K 1.59% 28
2014
Q4 		$2.64M Buy
69,302
+6,855
+11% +$251K 1.65% 25
2014
Q3 		$2.22M Buy
62,447
+3,235
+5% +$120K 1.49% 30
2014
Q2 		$2.31M Sell
59,212
-1,620
-3% -$60.5K 1.6% 26
2014
Q1 		$2.21M Sell
60,832
-1,488
-2% -$54.3K 1.63% 25
2013
Q4 		$2.16M Sell
62,320
-3,364
-5% -$108K 1.66% 25
2013
Q3 		$1.83M Buy
65,684
+8,692
+15% +$232K 1.55% 32
2013
Q2 		$1.53M Buy
+56,992
New +$1.57M 1.36% 39

Other funds holding XYL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Boston Research & Management's XYL Position: Q1 2026 in Review

Boston Research & Management reduced its Xylem (XYL) stake by 2.6% in Q1 2026, selling an estimated $199K and leaving 56,127 shares worth $6.71M. The position accounts for 1.59% of the portfolio, ranked #25.

Boston Research & Management first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.54M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Boston Research & Management held 56,127 shares of Xylem worth $6.71M as of Q1 2026.
  • Boston Research & Management sold 1,518 Xylem shares in Q1 2026, an estimated $199K.
  • Xylem made up 1.59% of Boston Research & Management's portfolio in Q1 2026, its #25 holding.
  • Boston Research & Management first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Xylem position peaked at $9.54M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.